Hotamisligil et al. (2015) mentioned that reducing the expression level of A-FABP and E-FABP can enhance glucose homeostasis and lower the risk of atherosclerosis in mice; circulating A-FABP is said to have an important hormonal function in the metabolic system [3]. Here, FABP4 is linked to atherosclerosis.